Markets |
Earnings cloud drags down Dow; Nasdaq gains on biotech
M&A
DJ: 17,949.59 -85.34 NAS: 5,014.10
+19.50 S&P: 2,097.29
-3.11
(Reuters) - U.S. stocks were a mixed bag on Tuesday, with
the Dow ending lower after a handful of uninspiring earnings reports while the Nasdaq closed near a record high
following a proposed biotech merger.
Travelers (TRV.N),
DuPont (DD.N) and
IBM (IBM.N)
shares weighed on the Dow Jones industrial average. DuPont reported lower sales in all of its
businesses and said a strong dollar would take a toll on its full-year
earnings. IBM also
mentioned currency effects
when it reported a fall in
revenue late on Monday.
DuPont ended the session 2.95 percent lower at $70.69 and IBM
fell 1.14 percent to $164.26.
March-quarter earnings season is in full swing, with almost 73 percent of the S&P 500 components that have reported
so far beating bottom-line expectations, but just 42.2 percent beating
expectations for revenue.
Investors struggled to gauge how much a strong dollar has hurt
U.S. multinationals, including technology companies like Facebook (FB.O),
Google (GOOGL.O),
Qualcomm (QCOM.O) and
Microsoft (MSFT.O) that
sell many of their products and services overseas and are expected to report
their earnings this week.
“There's a lot of cross-current in the earnings picture. Are we
at peak margins? Are we likely to hold, or might there be some downside?” said
Mark Foster, chief investment officer at Kirr Marbach & Co in Columbus,
Indiana. “People are pretty zeroed in on that."
The dollar .DXY has
gained almost 9 percent since the beginning of the year against a basket of major currencies,
hurting companies with large overseas operations.
Travelers reported a drop in quarterly net profit and its shares
ended down 4.01 percent.
The Dow Jones industrial
average .DJI fell 85.34 points, or 0.47 percent, to
end at 17,949.59. The S&P 500 .SPX lost 3.11 points, or 0.15 percent, to
2,097.29 and the Nasdaq Composite.IXIC added 19.50 points, or 0.39 percent, to
5,014.10.
The Nasdaq ended the day less than 35 points away
from its March 2000 all-time closing high.
Mylan (MYL.O)
shares rose 8.85 percent to end at $74.07 after Israeli drugmaker Teva (TEVA.N) made
an unsolicited offer of $82 per share, in what could be the drug industry's
largest takeover this year. Teva rose 1.37 percent. The Nasdaq Biotech index .NBI ended up 1.87
percent.
After the bell, Chipotle Mexican Grill (CMG.N) and
Yahoo (YHOO.O)
posted quarterly revenues that fell short of analyst estimates, and their
shares fell 4.5 percent and 1.19 percent, respectively.
Yum Brands (YUM.N) and
Broadcom (BRCM.O)
gained about 4 percent each after they posted earnings that beat modest
expectations.
First-quarter earnings of S&P 500 companies are expected to dip 2.2 percent,
while revenues are seen declining 3.1 percent, according to Thomson Reuters
data which includes companies that already reported.
Advancing issues outnumbered declining ones on the NYSE by 1,521
to 1,512, for a 1.01-to-1 ratio on the upside; on the Nasdaq, 1,381 issues fell and 1,346
advanced, for a 1.03-to-1 ratio favoring decliners.
The S&P 500 posted 12 new 52-week highs and no new
lows; the Nasdaq Composite, recorded 95 new highs and
27 new lows. About 5.9 billion shares changed hands
on U.S. exchanges, below the 6.2 billion daily average for the month to
date, according to BATS Global Markets.
Also:
Markets |
Wall Street's two major indexes drop; oil
falls
Oil prices fell on the Saudi news and anticipation of a
weekly build in U.S. crude stockpiles. A preliminary Reuters
survey showed that U.S. crude inventories likely rose by 2.4 million
barrels last week.
The euro gained slightly after euro zone finance ministers moved away
from fixing a deadline for Greek fiscal reforms.
No comments:
Post a Comment